Amarin reported $7.81M in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 766M 2787M
Acceleron Pharma XLRN:US $ -63.52M 0.05M
Aerie Pharmaceuticals AERI:US $ -38.69M 3.28M
Alnylam Pharmaceuticals ALNY:US $ -189.56M 10.73M
Amarin AMRN:US $ 7.81M 9.43M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
AstraZeneca AZN:LN 550M 1011M
Biocryst Pharmaceuticals BCRX:US $ -43.2M 21.09M
Epizyme EPZM:US $ -64.36M 5.91M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
GlaxoSmithKline GSK:LN 1395M 322M
Halozyme Therapeutics HALO:US $ 91.46M 63.56M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
JAZZ PHA JAZZ:US $ -363.32M 485.15M
Nektar Therapeutics NKTR:US $ -125.52M 2.55M
Neurocrine Biosciences NBIX:US $ 42.3M 10.2M
Novartis NOVN:VX SF 2896M 837M
Teva Pharmaceutical Industries TEVA:US $ 207M 129M